Priv.-Doz. Dr. G. Börger

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Seventeen malaria-naive volunteers received a recombinant Plasmodium falciparum vaccine (RLF) containing the carboxy- and the amino-terminal of the circumsporozoite protein (CSP) antigen without the central tetrapeptide repeats. The vaccine was formulated in liposomes with either a low or high dose of 3-deacylated monophosphoryl lipid A (MPL) and(More)
  • 1